{"id":"W2002876811","doi":"10.1038/sj.bjc.6601147","title":"Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"University Health Network","keywords":"Epirubicin; Irinotecan; Cisplatin; Medicine; Solid tumor; Camptothecin; Chemotherapy; Oncology; Internal medicine; Cancer; Cyclophosphamide; Chemistry; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108194,0.001310471,0.00285697,0.0004972327,0.0004107176,0.0006908328,0.0009955131,0.000827041,0.001320458],"category_scores_gemma":[0.0006998599,0.0006499221,0.0008811922,0.00063026,0.0009173799,0.0006552159,0.0003589516,0.003036157,0.0004762849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022922,"about_ca_system_score_gemma":0.001561572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006973658,"about_ca_topic_score_gemma":0.001513484,"domain_scores_codex":[0.9993935,0.0002665249,0.00002892556,0.0001145522,0.0001004444,0.00009609852],"domain_scores_gemma":[0.9992799,0.00008684699,0.0001536249,0.00005678064,0.00004675845,0.000375943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2994629,0.1440014,0.0174306,0.001101144,0.001551176,0.0008901299,0.0006934246,0.009581618,0.303778,0.0005275286,0.004148523,0.2168335],"study_design_scores_gemma":[0.1661848,0.7894774,0.01801589,0.00003122673,0.0003869963,0.0009883017,0.00006967565,0.002372025,0.01755356,0.0001673671,0.004717015,0.00003577511],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933918,0.002458421,0.001024267,0.0001843168,0.00005764176,0.001592804,0.000260381,0.00008098336,0.000949443],"genre_scores_gemma":[0.988181,0.002307423,0.004038571,0.0004179651,0.0001237918,0.002167675,0.001330664,0.00003754347,0.001395338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00285697,"threshold_uncertainty_score":0.007421851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008783136715454705,"score_gpt":0.2883614295485336,"score_spread":0.2795782928330788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}